Sisram Medical (HKG:1696) booked $19 million in attributable profit for 2025, falling from $25.1 million in 2024, according to a Hong Kong bourse filing Monday.
Earnings per share came in at $0.0406, compared with $0.0536 in the prior year.
Revenue rose by 4.7% year on year to $365.3 million, figures showed.
The company proposed a dividend of HK$0.095 per share.